Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partial Reprogramming Is Conserved from Insect to Mammal.

Cells·2026
Same author

Author Profile: Prabhat Tiwari.

Cytoskeleton (Hoboken, N.J.)·2025
Same author

Principal component-based clinical aging clocks identify signatures of healthy aging and targets for clinical intervention.

Nature aging·2024
Same author

<i>Drosophila</i>-A Model System for Developmental Biology.

Journal of developmental biology·2024
Same author

The Wnt Co-Receptor PTK7/Otk and Its Homolog Otk-2 in Neurogenesis and Patterning.

Cells·2024
Same author

MCC is a centrosomal protein that relocalizes to non-centrosomal apical sites during intestinal cell differentiation.

Journal of cell science·2022

Related Experiment Video

Updated: Aug 7, 2025

Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K

Using Optogenetics to Model Cellular Effects of Alzheimer's Disease.

Prabhat Tiwari1, Nicholas S Tolwinski2,3

  • 1Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506, USA.

International Journal of Molecular Sciences
|March 11, 2023
PubMed
Summary
This summary is machine-generated.

Alzheimer's disease (AD) involves amyloid beta (Aβ) plaques, but their exact role is debated. Optogenetics offers precise control to study Aβ aggregation and understand AD's causes.

Keywords:
Alzheimer’s diseaseacetylcholinesteraseamyloidoptogenetics

More Related Videos

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
06:14

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Published on: May 8, 2018

8.9K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

578

Related Experiment Videos

Last Updated: Aug 7, 2025

Fabrication of Amyloid-&#946;-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
06:52

Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease

Published on: July 6, 2019

9.4K
Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
06:14

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Published on: May 8, 2018

8.9K
Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
06:41

Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)

Published on: January 10, 2025

578

Area of Science:

  • Neuroscience
  • Biotechnology
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is a leading cause of dementia, with amyloid beta (Aβ) deposition as a key pathological hallmark.
  • The direct causative role of Aβ in dementia onset remains debated, evidenced by treatments clearing Aβ without cognitive improvement.

Purpose of the Study:

  • To explore novel approaches for understanding amyloid beta (Aβ) function in Alzheimer's disease (AD).
  • To investigate the utility of optogenetics for gaining precise spatiotemporal control over cellular processes relevant to AD.

Main Methods:

  • Discussion of optogenetic techniques, which utilize genetically encoded, light-dependent switches.
  • Application of optogenetics to control protein expression and aggregation dynamics in cellular models.

Main Results:

  • Optogenetics provides precise spatiotemporal control over cellular dynamics.
  • This technique allows for fine-tuning of protein aggregation, crucial for studying Aβ's role.

Conclusions:

  • Optogenetics presents a promising tool for dissecting the functional role of amyloid beta (Aβ) in Alzheimer's disease.
  • Precise manipulation of Aβ aggregation using optogenetics can enhance understanding of AD etiology.